LATEST NEWS: Schizophrenia not a mental illness, Pakistan's top court says - ISLAMABAD (Reuters) - Pakistan's top court has ruled that schizophrenia does not fall within its legal definition of mental disorders, clearing the way for the execution, as soon as next week, of a mentally ill man convicted of murder.
LATEST NEWS: Alkermes depression drug succeeds in key trial; shares surge - (Reuters) - Alkermes Plc's experimental depression drug significantly reduced symptoms in patients suffering from major depressive disorder who were not helped by standard treatments in a pivotal late-stage trial, the company said on Thursday, and its shares surged 47 percent.
LATEST NEWS: Bernie Sanders, U.S. Rep Cummings seek info on Ariad leukemia drug - (Reuters) - Former Democratic presidential candidate Bernie Sanders and U.S. Representative Elijah Cummings issued a letter on Thursday seeking information from Ariad Pharmaceuticals Inc on the "staggering" price increases for the company's leukemia drug.
LATEST NEWS: Obama says his departure may fix what ails Obamacare - MIAMI (Reuters) - President Barack Obama said on Thursday that his departure from office in January might be what it takes to begin to heal the political scars over Obamacare and allow for needed fixes to his signature healthcare law.
LATEST NEWS: Anti-inflammatory pills tied to heart failure risk - (Reuters Health) - Widely used non-steroidal anti-inflammatory drugs (NSAIDs) are associated with an increased risk of heart failure - even in people without a history of cardiac issues, a recent study suggests.
LATEST NEWS: Doctors think you don’t use enough sunscreen - (Reuters Health) - Even though most dermatologists recommend sunscreen to prevent skin cancer and premature aging of the skin, nearly all of them believe patients aren’t getting the message, a small U.S. study suggests.
LATEST NEWS: Gilead unveils promising hep C, fatty liver data; setbacks elsewhere - (Reuters) - Gilead Sciences Inc on Thursday announced high cure rates across all types of hepatitis C in late stage studies testing a triple drug combination, and said another experimental drug showed promise in reducing liver scarring known as fibrosis in a midstage trial.